Prescription drug · ANDA
Potassium Chloride NDC 0409-6651
Potassium chloride 149 mg/mL · Injection, Solution, Concentrate · Intravenous · Hospira, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0409-6651-06 | 00409665106 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-6651-06) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-6651-19)Marketed from Nov 10, 2005 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Potassium Chloride
- Generic name (nonproprietary)
- potassium chloride
- Active ingredients
- Potassium chloride — 149 mg/mL
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Labeler
- Hospira, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 080205
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 0409-6651_6367e84e-17df-4c2a-ba38-ce75e4fe1c96SPL ID 6367e84e-17df-4c2a-ba38-ce75e4fe1c96SPL set ID 559a0a8c-a8fe-40a5-b196-21f9308780abRxCUI 1860132, 1860136, 1860139UNII 660YQ98I10
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400409665106followed by a unit qualifier and the quantityPackage 00409-6651-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Potassium Chloride for Injection Concentrate, USP is indicated in the treatment of potassium deficiency states when oral replacement is not feasible.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 080205
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Potassium Chloride | Potassium chloride 149 mg/mL | Injection, Solution, ConcentrateIntravenous | Henry Schein, Inc. | 0404-9937 |
| Potassium Chloride | Potassium chloride 149 mg/mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | 0409-6653 |
| Potassium Chloride | Potassium chloride 149 mg/mL | Injection, Solution, ConcentrateIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1421 |
| Potassium Chloride | Potassium chloride 149 mg/mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | 0409-6635 |
| Potassium Chloride | Potassium chloride 149 mg/mL | Injection, Solution, ConcentrateIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1387 |